C34H39N5O5
Neat
597.72
-20°C
Room Temperature
Dihydroergostin; 3609-19-6; Ergotaman-3', 6', 18-trione, 2'-ethyl-9, 10-dihydro-12'-hydroxy-5'-(phenylmethyl)-, (5'alpha, 10alpha)-; RefChem:133807; 9, 10-Dihydroergostine; (6aR, 9R, 10aR)-N-[(1S, 2S, 4R, 7S)-7-benzyl-4-ethyl-2-hydroxy-5, 8-dioxo-3-oxa-6, 9-diazatricyclo[7.3.0.02, 6]dodecan-4-yl]-7-methyl-6, 6a, 8, 9, 10, 10a-hexahydro-4H-indolo[4, 3-fg]quinoline-9-carboxamide; DE-145; orb1697431; SCHEMBL23115955; DTXSID70957491; C34H39N5O5; AKOS040751576; FD159573; Dihydroergocristine Mesilate EP Impurity G; Dihydroergotamine Mesilate EP Impurity B; (6aR, 9R, 10aR)-N-((2R, 5S, 10aS, 10bS)-5-benzyl-2-ethyl-10b-hydroxy-3, 6-dioxooctahydro-2H-oxazolo[3, 2-a]pyrrolo[2, 1-c]pyrazin-2-yl)-7-methyl-4, 6, 6a, 7, 8, 9, 10, 10a-octahydroindolo[4, 3-fg]quinoline-9-carboxamide; N-(5-Benzyl-2-ethyl-10b-hydroxy-3, 6-dioxooctahydro-8H-[1, 3]oxazolo[3, 2-a]pyrrolo[2 and 1-c]pyrazin-2-yl)-6-methylergoline-8-carboximidic acid
(6aR, 9R, 10aR)-N-[(1S, 2S, 4R, 7S)-7-benzyl-4-ethyl-2-hydroxy-5, 8-dioxo-3-oxa-6, 9-diazatricyclo[7.3.0.02, 6]dodecan-4-yl]-7-methyl-6, 6a, 8, 9, 10, 10a-hexahydro-4H-indolo[4 and 3-fg]quinoline-9-carboxamide
InChI=1S/C34H39N5O5/c1-3-33(36-30(40)22-16-24-23-11-7-12-25-29(23)21(18-35-25)17-26(24)37(2)19-22)32(42)39-27(15-20-9-5-4-6-10-20)31(41)38-14-8-13-28(38)34(39,43)44-33/h4-7,9-12,18,22,24,26-28,35,43H,3,8,13-17,19H2,1-2H3,(H,36,40)/t22-,24-,26-,27+,28+,33-,34+/m1/s1